Plain-English translation of NCT07598396 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II clinical trial testing a medication called in people who have systemic lupus erythematosus (SLE), a serious autoimmune disease where the body attacks its own tissues. Some participants also have lupus nephritis, which means the disease has affected their kidneys. The trial will see if this new treatment is safe and effective for lupus patients.
Lupus is a chronic disease that can be difficult to control, and current treatments don't work well enough for all patients. Researchers are testing this medication to see if it offers a new option for people living with lupus and to understand how it works in the body.
You likely qualify if…
You likely don't qualify if…
You would receive regular injections of the medication under your skin as part of the study visits. Researchers will monitor how well the treatment works and check for any side effects through blood tests and other assessments. The study involves about 30 participants total, and you would be followed closely throughout the trial to see how your lupus responds to this new treatment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Brazil